Status:
COMPLETED
Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Patients Treated With Voriconazole
Eligibility:
All Genders
Brief Summary
The first goal of this study is to map all the subtherapeutic, therapeutic and supratherapeutic voriconazole plasma levels in the University Hospitals Leuven. The second objective is to optimize and v...
Eligibility Criteria
Inclusion
- Patients treated with voriconazole
- at least 1 voriconazole plasma level measured during therapy
Exclusion
- none
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01418833
Start Date
October 1 2010
End Date
January 1 2015
Last Update
February 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Vlaams-Brabant, Belgium, 3000